Plantar Herpes Zoster Following Heterologous Recombinant Adenovirus-Based Covid-19 Vaccine

Tehran University of Medical Sciences

Science Communicator Platform

Share By

Plantar Herpes Zoster Following Heterologous Recombinant Adenovirus-Based Covid-19 Vaccine Publisher Pubmed

Ayatollahi A¹ ; Robati RM^{2, 3} ; Firooz A¹

Source: Journal of Cosmetic Dermatology Published:2022

Abstract

[No abstract available]

Style	Citing Format
MLA	Ayatollahi A, Robati RM, Firooz A. "Plantar Herpes Zoster Following Heterologous Recombinant Adenovirus-Based Covid-19 Vaccine." Journal of Cosmetic Dermatology, vol. 21, no. 1, 2022, pp. 34-35.
APA	Ayatollahi A, Robati RM, Firooz A (2022). Plantar Herpes Zoster Following Heterologous Recombinant Adenovirus-Based Covid-19 Vaccine. Journal of Cosmetic Dermatology, 21(1), 34-35.
Chicago	Ayatollahi A, Robati RM, Firooz A. "Plantar Herpes Zoster Following Heterologous Recombinant Adenovirus-Based Covid-19 Vaccine." Journal of Cosmetic Dermatology 21, no. 1 (2022): 34-35.
Harvard	Ayatollahi A, Robati RM, Firooz A (2022) 'Plantar Herpes Zoster Following Heterologous Recombinant Adenovirus-Based Covid-19 Vaccine', Journal of Cosmetic Dermatology, 21(1), pp. 34-35.
Vancouver	Ayatollahi A, Robati RM, Firooz A. Plantar Herpes Zoster Following Heterologous Recombinant Adenovirus-Based Covid-19 Vaccine. Journal of Cosmetic Dermatology. 2022;21(1):34-35.
BibTex	@article{ author = {Ayatollahi A and Robati RM and Firooz A}, title = {Plantar Herpes Zoster Following Heterologous Recombinant Adenovirus-Based Covid-19 Vaccine}, journal = {Journal of Cosmetic Dermatology}, volume = {21}, number = {1}, pages = {34-35}, year = {2022} }
RIS	TY - JOUR AU - Ayatollahi A AU - Robati RM AU - Firooz A TI - Plantar Herpes Zoster Following Heterologous Recombinant Adenovirus-Based Covid-19 Vaccine JO - Journal of Cosmetic Dermatology VL - 21 IS - 1 SP - 34 EP - 35 PY - 2022 ER -